Medikaloka Hermina Future Growth
Future criteria checks 1/6
Medikaloka Hermina is forecast to grow earnings and revenue by 15.8% and 9.6% per annum respectively. EPS is expected to grow by 15.5% per annum. Return on equity is forecast to be 15.3% in 3 years.
Key information
15.8%
Earnings growth rate
15.5%
EPS growth rate
Healthcare earnings growth | 17.7% |
Revenue growth rate | 9.6% |
Future return on equity | 15.3% |
Analyst coverage | Good |
Last updated | 30 Apr 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 8,073,751 | 751,000 | 693,000 | 1,951,000 | 2 |
12/31/2025 | 7,252,094 | 714,200 | 456,604 | 1,445,000 | 7 |
12/31/2024 | 6,594,750 | 581,343 | -63,000 | 1,451,000 | 5 |
3/31/2024 | 6,137,900 | 519,392 | -475,821 | 1,391,603 | N/A |
12/31/2023 | 5,784,086 | 437,346 | -271,707 | 1,319,655 | N/A |
9/30/2023 | 5,489,476 | 401,911 | -122,712 | 1,167,233 | N/A |
6/30/2023 | 5,228,871 | 336,552 | -51,646 | 1,079,147 | N/A |
3/31/2023 | 5,045,373 | 296,249 | -26,339 | 1,044,610 | N/A |
12/31/2022 | 4,901,810 | 298,596 | -261,272 | 867,738 | N/A |
9/30/2022 | 4,884,192 | 468,353 | 720,340 | 2,083,345 | N/A |
6/30/2022 | 5,135,152 | 615,705 | 617,067 | 1,892,838 | N/A |
3/31/2022 | 5,493,169 | 823,971 | 677,633 | 1,921,469 | N/A |
12/31/2021 | 5,869,014 | 995,974 | 642,792 | 1,856,336 | N/A |
9/30/2021 | 6,160,265 | 984,449 | -450,591 | 585,680 | N/A |
6/30/2021 | 5,782,130 | 913,638 | -155,479 | 930,786 | N/A |
3/31/2021 | 5,017,031 | 684,631 | -237,869 | 776,409 | N/A |
12/31/2020 | 4,416,042 | 473,222 | 236,833 | 1,126,485 | N/A |
9/30/2020 | 3,826,030 | 307,234 | 485,466 | 1,233,835 | N/A |
6/30/2020 | 3,574,963 | 234,966 | 151,936 | 776,577 | N/A |
3/31/2020 | 3,713,290 | 270,753 | 242,020 | 846,451 | N/A |
12/31/2019 | 3,630,940 | 255,367 | -3,362 | 572,580 | N/A |
9/30/2019 | 3,457,550 | 224,197 | -345,366 | 266,934 | N/A |
6/30/2019 | 3,330,819 | 178,976 | -345,148 | 249,389 | N/A |
3/31/2019 | 3,213,504 | 143,733 | -328,973 | 281,638 | N/A |
12/31/2018 | 3,058,091 | 124,374 | -522,491 | 241,671 | N/A |
9/30/2018 | 3,002,728 | 122,143 | -449,194 | 372,664 | N/A |
6/30/2018 | 2,911,813 | 96,985 | -517,538 | 441,828 | N/A |
3/31/2018 | 2,783,426 | 99,344 | -468,306 | 408,610 | N/A |
12/31/2017 | 2,678,197 | 97,549 | N/A | 480,785 | N/A |
12/31/2016 | 2,234,263 | 61,996 | N/A | 362,845 | N/A |
12/31/2015 | 1,709,020 | 19,298 | N/A | 255,710 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: HEAL's forecast earnings growth (15.8% per year) is above the savings rate (6.8%).
Earnings vs Market: HEAL's earnings (15.8% per year) are forecast to grow slower than the ID market (26% per year).
High Growth Earnings: HEAL's earnings are forecast to grow, but not significantly.
Revenue vs Market: HEAL's revenue (9.6% per year) is forecast to grow slower than the ID market (10.8% per year).
High Growth Revenue: HEAL's revenue (9.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: HEAL's Return on Equity is forecast to be low in 3 years time (15.3%).